Joint assessment of health technologies by EU member states expected from 2024

04

Oct 2021

On 17 September 2021, the European Health and Digital Executive Agency (HaDEA) signed the Service Contract for the Provision of Joint Health Technology Assessment Work Supporting the Continuation of EU Cooperation on HTA.

From 2024, the EU member states will prepare joint benefit assessments of health technologies. In order to develop the basic methods for these joint assessments, the EU issued a call for tenders for a competent service provider. The contract has now been awarded to the EUnetHTA21 consortium, which comprises the following 13 organizations from the EUnetHTA: the Spanish Agency of Medicines and Medical Devices (AEMPS, Spain), the Italian Medicines Agency (AIFA, Italy), the Austrian Institute for Health Technology Assessment (AIHTA, Austria), the Federal Joint Committee (G-BA, Germany), the French National Authority for Health (HAS, France), the National Authority of Medicines and Health Products (INFARMED, Portugal), the Institute for Quality and Efficiency in Health Care (IQWiG, Germany), the Belgian Health Care Knowledge Center (KCE, Belgium), the National Centre for Pharmacoeconomics (NCPE, Ireland), the National Institute of Pharmacy and Nutrition (NIPN, Hungary), the Norwegian Medicines Agency (NOMA, Norway), and the Dental and Pharmaceutical Benefits Agency (TLV, Sweden).

The project will start in September 2021 and will run for two years (until September 2023). Over these two years, the EU Commission will fund the further development of the basic methods for implementing the EU HTA regulation with a total of three million euros.

Initially, joint HTA reports will be prepared for all cancer drugs and all advanced therapy medicinal products (e.g., cell therapy and gene therapy). In a second step, drugs for rare diseases will also be jointly assessed, followed by all other drugs and medical devices.

The full details in English can be found here or in German here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.

The latest related news

15

Oct 2021

The Scottish Health Technologies Group (SHTG) is a national health technology assessment (HTA) agency providing advice to NHSScotland on the use of new and existing health technologies, likely to have a significant impact on healthcare. In the third quarter of 2021, SHTG published only one report in relation to HeartFlow fractional flow reserve computerized tomography (FFRCT). Currently, the SHTG is working on assessments of technologies in the field of diabetes, digital health, surgical procedures, and other topics.

Read more

08

Oct 2021

In September 2021, the National Institute for Health and Care Excellence (NICE) published three new Interventional Procedure Guidance (transapical transcatheter mitral valve-in-valve implantation for a failed surgically implanted mitral valve bioprosthesis, transapical transcatheter mitral valve-in-ring (TMVIR) after failed annuloplasty for mitral valve repair, and lateral elbow resurfacing for arthritis), and two new Medtech Innovation Briefings (Carnation Ambulatory Monitor, OrganOx metra for liver transplant). Also, one clinical guideline was updated.

Read more

07

Oct 2021

On September 10, 2021, it was announced that the Government of Spain had increased the budget allocated to the Spanish Network of Agencies for the Evaluation of Health Technologies and Benefits (RedETS) by 48.2% (compared to last year) for the development of the annual work plan. In total, the 2021 budget for the evaluation of health technologies in the National Health System amounts to €6,149,510. As a consequence of the budget increase, the RedETS 2021 Work Plan has included three new lines of evaluation.

Read more

06

Oct 2021

Health Information and Quality Authority (HIQA) develops national HTA guidelines to support decision-making in Ireland. In the third quarter of 2021, Health Information and Quality Authority published three reports in relation to in-vitro diagnostics, including newborn bloodspot screening, tests for hepatitis C and SARS-CoV-2.

Read more

05

Oct 2021

In September 2021, the National Institute for Health and Care Excellence (NICE) published three new Interventional Procedure Guidance on transapical transcatheter mitral valve-in-valve implantation for a failed surgically implanted mitral valve bioprosthesis, transapical transcatheter mitral valve-in-ring (TMVIR) after failed annuloplasty for mitral valve repair, and lateral elbow resurfacing for arthritis

Read more